The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s disease.